Results 1 - 10 of 145
[PROJECT] PANCARESURFUP - PanCare Childhood and Adolescent Cancer Survivor Care and Follow-up Studies
ID: 257505
Start date: 2011-02-01, End date: 2017-01-31
Over the last 40 years, treatment for childhood and adolescent cancer has improved greatly; 5- year survival after childhood cancer is now 80% in developed countries. Approximately 1 individual in 750 of young adults is now a childhood cancer survivor. Epidemiologic data on t...
Programme: FP7-HEALTH
Record Number: 97692
Last updated on: 2017-05-29
[PROJECT] MOODINFLAME - Early diagnosis, treatment and prevention of mood disorders targetting the activated inflammatory response system
ID: 222963
Start date: 2008-11-01, End date: 2013-04-30
Partners come from 10 European countries to achieve two main objectives: A) The further exploration of 3 animal models (the OBX rat, GS rat and NOD mouse) characterized by an activated immune response system (IRS), an abnormal tryptophan catabolism and a depressive-like behav...
Programme: FP7-HEALTH
Record Number: 89344
Last updated on: 2017-06-12
[PROJECT] COPHES - European coordination action on human biomonitoring
ID: 244237
Start date: 2009-12-01, End date: 2012-11-30
This proposal has been elaborated by a consortium of 35 partners coming from 27 European countries and including scientists, government institutions and authorities, NGOs and industry. The main goal is to develop a coherent approach to HBM in Europe as requested by ACTION 3 o...
Programme: FP7-ENVIRONMENT
Record Number: 93956
Last updated on: 2017-05-29
[PROJECT] SYSKID - Systems biology towards novel chronic kidney disease diagnosis and treatment
ID: 241544
Start date: 2010-01-01, End date: 2014-12-31
Chronic kidney disease (CKD) affects up to 10% of the population. Besides eventual progression towards end stage renal disease CKD impacts the patient’s quality of life by causing serious comorbidities including cardiovascular complications and bone metabolism disorders. On t...
Programme: FP7-HEALTH
Record Number: 92677
Last updated on: 2017-05-25
[PROJECT] DALI - Vitamin D And LIfestyle Intervention for Gestational Diabetes Mellitus (GDM) Prevention
ID: 242187
Start date: 2010-03-01, End date: 2015-12-31
Europe is facing a rapidly growing threat from Type 2 diabetes mellitus (T2D), which is undoubtedly associated with an unhealthy diet and a more sedentary lifestyle. Evidence is accumulating that gestational diabetes mellitus (GDM) may be playing a role in this process. Thus ...
Programme: FP7-HEALTH
Record Number: 93700
Last updated on: 2017-05-29
[PROJECT] EFRAIM - Mechanisms of early protective exposures on allergy development
ID: 211911
Start date: 2008-02-01, End date: 2012-01-31
Allergy has developed into a major health concern in Europe. Allergic diseases can currently be managed effectively but not cured. The onset of allergies stars early in life and there is increasing evidence that exogenous factors affecting the incidence of these illnesses exe...
Programme: FP7-KBBE
Record Number: 88400
Last updated on: 2017-05-29
[PROJECT] RESTORE - REsearch into implementation STrategies to support patients of different ORigins and language background in a variety of European primary care settings
ID: 257258
Start date: 2011-04-01, End date: 2015-03-31
This project is concerned with optimising the delivery of primary healthcare to European citizens who are migrants who experience language and cultural barriers in host countries. We focus on the implementation of evidence-based health information (e.g. guidelines to enhance ...
Programme: FP7-HEALTH
Record Number: 97691
Last updated on: 2017-05-29
[PROJECT] ASSET - ASSET: Analysing and Striking the Sensitivities of Embryonal Tumours
ID: 259348
Start date: 2010-11-01, End date: 2016-04-30
Cancer is hallmarked by multiple genetic aberrations that lead to a functional derangement of cellular signalling networks. Embryonal tumours (ETs) comprising neuroblastoma, medulloblastoma and Ewing sarcoma, occur early in life, and thus may reveal pathogenetically relevant ...
Programme: FP7-HEALTH
Record Number: 97171
Last updated on: 2017-05-29
[PROJECT] RATHER - Rational Therapy for Breast Cancer: Individualized Treatment for Difficult-to-Treat Breast Cancer Subtypes
ID: 258967
Start date: 2011-01-01, End date: 2018-06-30
Cancer genotyping has identified a number of correlations between mutations in specific genes and responses to targeted anti-cancer drugs, with many mutations occurring in kinases or downstream signaling components. While there are several ongoing large-scale genome re-sequen...
Programme: FP7-HEALTH
Record Number: 97660
Last updated on: 2017-07-16
[REPORT SUMMARY] Periodic Report Summary 4 - RATHER (Rational Therapy for Breast Cancer: Individualized Treatment for Difficult-to-Treat Breast Cancer Subtypes)
Project Context and Objectives: Cancer genotyping has identified a number of correlations between mutations in specific genes and responses to targeted anti-cancer drugs, with many mutations occurring in kinases or downstream signalling components. The RATHER consortium are...
Programme: FP7-HEALTH
Record Number: 201776
Last updated on: 2017-07-25
List retrieved on: 2017-08-02
